Objective : To investigate the therapeutic effects of HangAm-Plus (HAP) on advanced gastric cancer patient.
Methods : A 53 year old male patient diagnosed with advanced gastric cancer (T3N3M1) was admitted to EWCC (East-West Cancer Center) on Nov. 20008. He had refused to go through the standard cancer regimen after having total gastrectomy on Jul 2008. The patient was treated with HAP (3,000 mg/day) for the period of 11 months from Nov 27th, 2008 to Oct 10th, 2009. Computed tomography (CT) and endoscopy were used to evaluate the disease progression of the patient.
Results : HAP treatment was well tolerated by the patient. Patient has shown 25 months of stable disease condition up until now.
Conclusion : This case study supports HAP's potential efficacy in treating advanced gastric cancer patients.